• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,100.47 109.25
( 0.14%)
Global Indices
Nasdaq
51,823.54 -118.08
(-0.23%)
Dow Jones
7,358.68 -19.81
(-0.27%)
Hang Seng
69,065.93 -3,300.41
(-4.56%)
Nikkei 225
10,515.14 -14.75
(-0.14%)
Forex
USD-INR
94.55 -0.19
(-0.20%)
EUR-INR
107.36 -0.64
(-0.59%)
GBP-INR
124.56 -0.65
(-0.52%)
JPY-INR
0.58 0.00
(-0.30%)

EQUITY - MARKET SCREENER

Shukra Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
524632
INE551C01044
2.051431
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
58.92
1289.99
EPS(TTM)
Face Value()
Div & Yield %
0.5
1
0.03
 

the bombay trading corporation ltd
IST reports consolidated net loss of Rs 9.50 crore in the March 2026 quarter
May 30,2026
Net loss of IST reported to Rs 9.50 crore in the quarter ended March 2026 as against net profit of Rs 16.77 crore during the previous quarter ended March 2025. Sales rose 21.97% to Rs 34.42 crore in the quarter ended March 2026 as against Rs 28.22 crore during the previous quarter ended March 2025.

For the full year,net profit rose 9.70% to Rs 153.50 crore in the year ended March 2026 as against Rs 139.93 crore during the previous year ended March 2025. Sales rose 9.68% to Rs 126.16 crore in the year ended March 2026 as against Rs 115.03 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales34.4228.22 22 126.16115.03 10
OPM %37.1370.27 -59.1870.88 -
PBDT-5.9522.84 PL 205.13183.02 12
PBT-7.5321.49 PL 199.38177.64 12
NP-9.5016.77 PL 153.50139.93 10